ScholarIQanswers from OpenAlex & ORCID
Ulrich‐Frank Pape
ResearcherPublications, citations & collaboration network
Ulrich‐Frank Pape is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ulrich‐Frank Pape have?
ScholarIQindexed works
Ulrich‐Frank Pape has 181 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ulrich‐Frank Pape have?
ScholarIQcitation count
Ulrich‐Frank Pape has 8,756 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ulrich‐Frank Pape?
ScholarIQh-index
Ulrich‐Frank Pape has an h-index of 36 in OpenAlex.
What is the i10-index of Ulrich‐Frank Pape?
ScholarIQi10-index
Ulrich‐Frank Pape has an i10-index of 68 in OpenAlex.
What is the ORCID of Ulrich‐Frank Pape?
ScholarIQorcid
The ORCID for Ulrich‐Frank Pape is on the source record.
What is the OpenAlex record for Ulrich‐Frank Pape?
ScholarIQopenalex
The OpenAlex for Ulrich‐Frank Pape is on the source record.
What are the most-cited papers on Ulrich‐Frank Pape?
ScholarIQmost cited works
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger, Klaus‐Jochen Klose, Peter Barth, M. Wied, Christina Mayer, Behnaz Aminossadati, Ulrich‐Frank Pape, Michael Bläker, Jan Harder, Christian Arnold, Thomas M. Gress, Rudolf Arnold
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
Marianne Pavel, Dermot O’Toole, Frederico Costa, Jaume Capdevila, Danae C. Gross, Réza Kianmanesh, E. P. Krenning, Ulrich Knigge, Ramón Salazar, Ulrich‐Frank Pape, Kjell Öberg, all other Vienna Consensus Conference participants
Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors—The International Lanreotide and Interferon Alfa Study Group
Siegbert Faiss, Ulrich‐Frank Pape, Michael Böhmig, Yvonne Dörffel, Ulrich Mansmann, W. Golder, E. O. Riecken, Bertram Wiedenmann
ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
Ulrich‐Frank Pape, Aurel Perren, Bruno Niederle, David J. Gross, Thomas M. Gress, Frederico Costa, Rudolf Arnold, Timm Denecke, Ursula Plöckinger, Ramón Salazar, Ashley Grossman
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Ulrich‐Frank Pape, Henning Jann, Jacqueline Müller‐Nordhorn, Angelina Bockelbrink, Uta Berndt, Stefan N. Willich, Martin Koch, Christoph Röcken, Guido Rindi, Bertram Wiedenmann